West Pharmaceutical Services, Inc.

NYSE:WST

Medical - Instruments & Supplies

Healthcare
$404.02 +1.56%

+$5.04 today

Market cap
$28.14B
Beta
1.18
P/E (TTM)
43.6
EPS (TTM)
$7.54
Dividend yield
0.26%
52W Low $206.80High $336.82

Volume 0.59M

Average 0.85M

WST Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

West Pharmaceutical Services, Inc.NYSE: WST

Weighted Avg Shares · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares declines year over year

Q2 FY2026 weighted avg shares of 70.8M shares fell 2.1% year over year, behind the -1.1% change in trailing-twelve-month weighted avg shares. Sequentially, it fell 1.7% from the prior quarter. Over 3 fiscal years it compounded at -0.9% a year.

Context

  • Weighted avg shares increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -2.1% toward the trailing-twelve-month pace of -1.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
70.8M-1.7% QoQ
Last fiscal yearDec 2025
72.3M-1.0% YoY
LTMJun 2026
71.85M-1.1% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-2.1%——
1 year-1.0%——
3-year CAGR-0.9%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
72.3M USD
Year-over-year change
-1.0%
4-year CAGR
-0.7%

Weighted Avg Shares vs competitors

How WST compares with its peers on the latest reported figures

  • WST's LTM Jun 2026 weighted avg shares of 71.85M shares is the 2nd highest of the 5 companies compared; the peer median is 56.32M shares.
  • Its year-over-year change of -1.1% is the 4th highest of 5, against a peer median of +0.5%.
  • Over three fiscal years its annual growth of -0.9% compares with a peer median of +1.1%.
WST Competitors Peer median
Weighted Avg Shares for WST and competitors
Company Period LTM YoY 3-year CAGR
STVNStevanato Group S.p.A.LTM Jun 2026273M +0.0%+1.0%
WSTWest Pharmaceutical Services, Inc.LTM Jun 202671.85M -1.1%-0.9%
ATRAptarGroup, Inc.LTM Jun 202664.65M -2.5%+0.2%
BLFSBioLife Solutions, Inc.LTM Mar 202647.98M +3.2%+4.0%
ICUIICU Medical, Inc.LTM Jun 202624.78M +1.0%+1.1%
Peer median (excluding WST) 56.32M+0.5%+1.1%

Competitors are the stored peer set for WST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.83B2.89B2.95B2.89B3.07B
Cost of Revenue1.66B1.75B1.82B1.89B1.97B
Gross Profit1.17B1.14B1.13B1B1.1B
Gross Margin41.5%39.5%38.4%34.6%35.9%
Research & Development52.8M58.5M68.4M69.1M74.3M
Selling, General & Admin361.9M316.9M353.4M338.5M393.1M
Operating Expenses414.7M375.4M421.8M407.6M485.9M
Depreciation & Amortization122.3M120.6M137.3M155.4M171.4M
EBITDA879.7M808.1M844.1M743.8M770.6M
EBITDA Margin31.1%28.0%28.6%25.7%25.1%
Operating Income758.7M763.5M710.9M594.6M617.4M
Operating Margin26.8%26.5%24.1%20.6%20.1%
Interest Income1M5.1M28M19.6M17.7M
Interest Expense8.5M7.6M8.8M2.9M600K
Other Income / Expenses10.3M(62.9M)4.8M5.6M(2.1M)
Income Before Tax769M700.6M715.7M600.2M615.3M
Pre-Tax Margin27.2%24.3%24.3%20.7%20.0%
Income Tax Expense107.2M114.7M122.3M107.5M121.6M
Net Income661.8M585.9M593.4M492.7M493.7M
Net Margin23.4%20.3%20.1%17.0%16.1%
EPS (Basic)8.907.887.996.756.83
EPS (Diluted)8.677.737.886.696.80
Weighted Avg Shares74.4M74.4M74.3M73M72.3M
Weighted Avg Shares (Diluted)76.3M75.8M75.3M73.7M72.7M

West Pharmaceutical Services, Inc.

NYSE:WST

Intrinsic Alpha fair value

Locked

Current Price

$404.02

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.